Trump officials meet with drug companies to push for voluntary price cuts

HHS officials have reportedly been meeting with pharmaceutical companies to seek voluntary cuts in drug prices. It is not yet clear whether any drug companies have agreed to cut their prices voluntarily.

HHS officials have reportedly been meeting with pharmaceutical companies to seek voluntary cuts in drug prices. It is not yet clear whether any drug companies have agreed to cut their prices voluntarily. President Donald Trump said at the end of May that "in 2 weeks" drug companies would "announce voluntary massive drops in prices." Officials have not provided any more details on what he meant with those remarks. The 2-week mark is coming up this week. The administration last month put forward a long-awaited plan aimed at lowering drug prices, which included possible proposals such as reclassifying drugs within Medicare to increase competition and requiring drug companies to disclose their prices in television ads. Democrats criticized the proposal as being too soft on drug companies, as it leaves out more sweeping items like having Medicare negotiate drug prices directly.